CAS#2803881-11-8|(2- (2,6-dioxopiperidin-3-il) -3-oxoisoindolin-5-il) methyl (2-fluoro-5- (trifluoromethoxy) fenil) carbamate

Non pwodwi	(2- (2,6-dioxopiperidin-3-il) -3-oxoisoindolin-5-il) methyl (2-fluoro-5- (trifluoromethoxy) fenil) carbamate	Fòmil estrikti	​
CAS No.	2803881-11-8	Pwa molekilè	495.38
Aparisyon	Solid	Pwen bouyi	644.0 ± 55.0 degre (prevwa)
Asay	99%	Pakèt	5mg; 10mg
Fòmil	C22H17F4N3O6

 

Aplikasyon

 

• MRT-2359 is a potent, orally active and selective GSPT1 depressant (IC50: >30 nm ak<300 nM) that specifically induces apoptosis dependent on protein translation. MRT-2359 exhibits significant and preferred anti-proliferative activity in a variety of cancer cell lines, especially MYC-driven cell lines, such as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with high expression of N-Myc or L-Myc. MRT-2359 inhibits the growth of drug-resistant NSCLC and SCLC cells, making it suitable for cancer research[1][2][3][4][5].

 

Anbake

 

 

 

Baj popilè: CAS#2803881-11-8|(2- (2,6-dioxopiperidin-3-il) -3-oxoisoindolin-5-il) metil (2-fluoro-5- (trifluoromethoxy) fenil) carbamate, Lachin CAS#280381-11-8|(2- (2,6-dioxopiperidin-3-il) -3-oxoisoindolin-5-il) methyl (2-fluoro-5- (trifluoromethoxy) fenil) manifaktirè carbamate, founisè, faktori